Mereo BioPharma Group (MREO) Insider Trading & Ownership $2.80 +0.04 (+1.45%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$2.74 -0.06 (-2.29%) As of 06/17/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mereo BioPharma Group (NASDAQ:MREO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$980.76K Get MREO Insider Trade Alerts Want to know when executives and insiders are buying or selling Mereo BioPharma Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MREO Insider Buying and Selling by Quarter Mereo BioPharma Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2024Charles SermonGeneral CounselSell9,980$4.47$44,610.60 9/12/2024Christine Ann FoxCFOSell9,128$4.47$40,802.16 9/12/2024Denise Scots-KnightCEOSell28,611$4.47$127,891.17 9/12/2024John A LewickiInsiderSell5,212$4.47$23,297.64 8/22/2024Deepika PakianathanDirectorSell105,244$4.43$466,230.92 6/25/2024Charles SermonGeneral CounselSell14,202$3.69$52,405.38 6/25/2024Christine Ann FoxCFOSell12,990$3.69$47,933.10 6/25/2024Denise Scots-KnightCEOSell40,712$3.69$150,227.28 6/25/2024John A LewickiInsiderSell7,416$3.69$27,365.04 (Data available from 1/1/2013 forward) MREO Insider Trading Activity - Frequently Asked Questions Who is on Mereo BioPharma Group's Insider Roster? The list of insiders at Mereo BioPharma Group includes Alexandra Hughes-Wilson, Charles Sermon, Christine Ann Fox, Deepika Pakianathan, Denise Scots-Knight, and John A Lewicki. Learn more on insiders at MREO. What percentage of Mereo BioPharma Group stock is owned by insiders? 5.50% of Mereo BioPharma Group stock is owned by insiders. Learn more on MREO's insider holdings. Which Mereo BioPharma Group insiders have been selling company stock? The following insiders have sold MREO shares in the last 24 months: Alexandra Hughes-Wilson ($298,283.04), Charles Sermon ($97,015.98), Christine Ann Fox ($88,735.26), Deepika Pakianathan ($466,230.92), Denise Scots-Knight ($278,118.45), and John A Lewicki ($50,662.68). How much insider selling is happening at Mereo BioPharma Group? Insiders have sold a total of 333,927 Mereo BioPharma Group shares in the last 24 months for a total of $1,279,046.33 sold. Mereo BioPharma Group Key ExecutivesDr. Denise Vera Scots-Knight Ph.D. (Age 65)Co-Founder, CEO & Executive Director Compensation: $890.56kMr. Charles Edward Sermon (Age 55)Co-Founder, General Counsel, Business Development & Company Secretary Compensation: $625.79kMs. Christine Fox CPA (Age 43)Chief Financial Officer Compensation: $569.77kDr. John P. Richard M.B.A. (Age 67)Co-Founder & Chief Business Officer Dr. John A. Lewicki Ph.D. (Age 72)Chief Scientific Officer Dr. Jackie Parkin (Age 66)Senior VP & Therapeutic Head Ms. Alexandra Hughes-Wilson (Age 53)Chief of Patient Access & Commercial Planning Dr. Suba Krishnan (Age 59)Senior Vice President of Clinical Development Mr. Bo KaraSenior VP and Head of Pharmaceutical Development & CMC More Insider Trading Tools from MarketBeat Related Companies Dyne Therapeutics Insider Ownership Edgewise Therapeutics Insider Ownership Centessa Pharmaceuticals Insider Ownership Adaptive Biotechnologies Insider Ownership 89bio Insider Ownership Janux Therapeutics Insider Ownership ARS Pharmaceuticals Insider Ownership Ocular Therapeutix Insider Ownership Vera Therapeutics Insider Ownership ANI Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:MREO) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.